Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection
- PMID: 20444242
- DOI: 10.1111/j.1432-2277.2010.01090.x
Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection
Abstract
In the current era of organ shortages and long wait times for life-saving transplants, marginal or extended donors are increasingly being considered; one such category of marginal organs is from donors with a previous history of malignancy. Melanoma in particular has been associated with increased risk of developing late recurrence. In this report, we describe a case of fatal donor melanoma transmission to a 64-year-old lung transplant recipient 32 years after surgical excision of the melanoma. Based on this report and review of the available literature, we conclude that a history of donor melanoma, regardless of the stage and time interval from 'curative' surgical resection, should remain a strong relative contraindication to transplantation.
Similar articles
-
Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review.Clin Transplant. 2009 Aug-Sep;23(4):571-4. doi: 10.1111/j.1399-0012.2008.00928.x. Clin Transplant. 2009. PMID: 19681978 Review.
-
Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.Clin Transpl. 2003:89-100. Clin Transpl. 2003. PMID: 15387100
-
Transmission of donor cancer into cardiothoracic transplant recipients.Surgery. 2001 Oct;130(4):660-6; discussion 666-8. doi: 10.1067/msy.2001.117102. Surgery. 2001. PMID: 11602897
-
Living lobar lung transplantation.Respir Care Clin N Am. 2004 Dec;10(4):563-79. doi: 10.1016/j.rcc.2004.06.004. Respir Care Clin N Am. 2004. PMID: 15585183 Review.
-
Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for thoracic organ transplantation.Clin Transpl. 1997:29-43. Clin Transpl. 1997. PMID: 9919389
Cited by
-
Malignancy after lung transplantation.Ann Transl Med. 2020 Mar;8(6):416. doi: 10.21037/atm.2020.02.126. Ann Transl Med. 2020. PMID: 32355860 Free PMC article. Review.
-
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?PLoS One. 2018 Apr 16;13(4):e0195497. doi: 10.1371/journal.pone.0195497. eCollection 2018. PLoS One. 2018. PMID: 29659587 Free PMC article.
-
Donor transmission of melanoma following renal transplant.Case Rep Transplant. 2012;2012:764019. doi: 10.1155/2012/764019. Epub 2012 Nov 4. Case Rep Transplant. 2012. PMID: 23259141 Free PMC article.
-
T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.Semin Immunopathol. 2017 Apr;39(3):255-268. doi: 10.1007/s00281-016-0614-9. Epub 2017 Jan 10. Semin Immunopathol. 2017. PMID: 28074285 Review.
-
Melanoma in organ transplant recipients: incidence, outcomes and management considerations.J Skin Cancer. 2012;2012:404615. doi: 10.1155/2012/404615. Epub 2012 Nov 25. J Skin Cancer. 2012. PMID: 23227339 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical